Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India
- 108 Downloads
Methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T, A1298C) has been implicated in increased plasma homocysteine (Hcy) levels. The present study was designed to investigate the association between MTHFR polymorphism and increased Hcy levels in subarachnoid haemorrhage (SAH) patients. A total of 150 subjects from North India were included in the study, comprising of 100 SAH patients and 50 healthy controls. Plasma Hcy levels was determined and MTHFR polymorphism (C677T, A1298C) was screened by High resolution melting (HRM) analysis. Plasma Hcy levels were found to be significantly higher (p < 0.001) in SAH patients than in healthy controls. No significant difference in the genotype and allele frequency of MTHFR A1298C was observed. However, frequency of MTHFR C677T genotype, CT (53% vs. 20%; p < 0.001) and TT (15% vs. 2%; p < 0.05) was significantly higher in SAH group as compared to healthy controls. The frequency of T allele (41.5% vs. 12%; p < 0.001) was also found to be higher in SAH patients in comparison to healthy controls. Furthermore, Hcy levels were higher in SAH patients with TT genotype than in patients having CT genotype, whereas CC genotype had lower Hcy levels. The study suggests that higher frequency of MTHFR C677T allele may contribute to etiopathology of SAH through increase in Hcy levels.
KeywordsHomocysteine Methylenetetrahydrofolate reductase MTHFR A1298C MTHFR C677T Subarachnoid haemorrhage Single nucleotide polymorphism
Coronary artery diseases
High resolution melting
Single nucleotide polymorphism
The financial assistance provided by Department of Bio-Technology (DBT), Govt. of India, New Delhi [grant number BT/361/NE/TBP/2012] is acknowledged. The fellowship to MK from the University Grants Commission (UGC), New Delhi [F.17-7(J)/2004(SA-1)] is also acknowledged. The authors also acknowledge UGC-Special Assistance Programme (UGC-SAP) Departmental Research Support-II (DRS-II). The financial assistance provided by the Department of Science and Technology (DST), New Delhi under Promotion of University Research and Scientific Excellence (PURSE) grant is also acknowledged. The help of Prof. Suresh K. Sharma from the Department of Statistics, Panjab University in data analysis is gratefully acknowledged.
Compliance with ethical standards
All experiments were accordance with the ethical standards and were approved by the Institutional Ethics Committee of PGIMER (NK/872/M.Ch./542).
Informed consent was obtained from all participants included in the study.
Conflict of interest
The authors state no conflict of interest.
- Biswas A, Ranjan R, Meena A et al (2009) Homocystine Levels, Polymorphisms and the Risk of Ischemic Stroke in Young Asian Indians. J Stroke Cerebrovasc Dis 18:103–110. https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.09.014 CrossRefPubMedGoogle Scholar
- Cronin S, Furie KL, Kelly PJ (2005) Dose-Related Association of MTHFR 677T Allele With Risk of Ischemic Stroke: Evidence From a Cumulative Meta-Analysis. Stroke 36:1581–1587. https://doi.org/10.1161/01.STR.0000169946.31639.af CrossRefPubMedGoogle Scholar
- Dhandapani SS, Manju D, Vivekanandhan S et al (2010) Prospective longitudinal study of biochemical changes in critically ill patients with severe traumatic brain injury: Factors associated and outcome at 6 months. Indian J Neurotrauma 7:23–27. https://doi.org/10.1016/S0973-0508(10)80007-3 CrossRefGoogle Scholar
- Dhandapani S, Goudihalli S, Mukherjee KK et al (2015b) Prospective study of the correlation between admission plasma homocysteine levels and neurological outcome following subarachnoid hemorrhage: A case for the reverse epidemiology paradox? Acta Neurochir 157:399–407. https://doi.org/10.1007/s00701-014-2297-0 CrossRefPubMedGoogle Scholar
- Li Z, Sun L, Zhang H et al (2003) Elevated Plasma Homocysteine Was Associated With Hemorrhagic and Ischemic Stroke, but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke: A Multicenter Case-Control Study in China. Stroke 34:2085–2090. https://doi.org/10.1161/01.STR.0000086753.00555.0D CrossRefPubMedGoogle Scholar
- Mansoori N, Tripathi M, Luthra K, et al (2012) MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer’s and vascular dementia and their epistatic interaction. Neurobiol Aging 33:1003.e1–1001003.e8. https://doi.org/10.1016/j.neurobiolaging.2011.09.018 CrossRefGoogle Scholar
- Modi M, Prabhakar S, Majumdar S et al (2005) Hyperhomocysteinemia as a risk factor for ischemic stroke: an Indian scenario. Neurol India 53:297-301-2Google Scholar
- Panigrahi I, Chatterjee T, Biswas A et al (2006) Role of MTHFR C677T polymorphism in ischemic stroke. Neurol India 54:48-50-2Google Scholar
- Serapinas D, Boreikaite E, Bartkeviciute A et al (2017) The importance of folate, vitamins B6 and B12 for the lowering of homocysteine concentrations for patients with recurrent pregnancy loss and MTHFR mutations. Reprod Toxicol 72:159–163. https://doi.org/10.1016/j.reprotox.2017.07.001 CrossRefPubMedGoogle Scholar
- Tripathi R, Tewari S, Singh PK, Agarwal S (2010) Association of homocysteine and methylene tetrahydrofolate reductase (MTHFR C677T) gene polymorphism with coronary artery disease (CAD) in the population of North India. Genet Mol Biol 33:224–228. https://doi.org/10.1590/S1415-47572010005000026 CrossRefPubMedPubMedCentralGoogle Scholar
- Wilcken B, Bamforth F, Li Z et al (2003) Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 40:619–625. https://doi.org/10.1136/jmg.40.8.619 CrossRefPubMedPubMedCentralGoogle Scholar
- Zhou F, chen B, Chen C et al (2015) Elevated Homocysteine Levels Contribute to Larger Hematoma Volume in Patients with Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis 24:784–788. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.11.005 CrossRefPubMedGoogle Scholar